The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Linker     3-[4-[bis(4-methoxyphenyl)- phenyl...

Synonyms: AC1LCF6L, 172042-EP2281817A1
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Linker

  • Epidermolysis bullosa simplex (Weber-Cockayne) associated with a novel missense mutation of Asp328 to Val in Linker 12 domain of keratin 5 [1].
  • To overcome multi-drug resistance, we engineered a diphtheria fusion protein by fusing human interleukin-3 (IL3) to a truncated form of diphtheria toxin (DT) with a (G4S)2 linker (L), expressed and purified the recombinant protein, and tested the cytotoxicity of the DTLIL3 molecule on human leukemias and normal progenitors [2].
  • Targeted prodrug treatment of HER-2-positive breast tumor cells using trastuzumab and paclitaxel linked by A-Z-CINN Linker [3].
 

High impact information on Linker

  • Our results indicate that the PKCtheta-induced phosphorylation of CARMA1 likely occurs on Ser552 on the Linker region of CARMA1 [4].
  • 3. Linker-scanning mutations demonstrated that multiple interdependent elements are required for inducibility by PMA and also for synergy with IL-4 [5].
  • Receptor and kinase activation is linked to distal signaling pathways (PLC-gamma1 activation, Ca2+ influx, PKC activation and Ras/Erk activation) via the adapter protein LAT (Linker for Activation of T cells) [6].
  • The Role of X/Y Linker Region and N-terminal EF-hand Domain in Nuclear Translocation and Ca2+ Oscillation-inducing Activities of Phospholipase C{zeta}, a Mammalian Egg-activating Factor [7].
  • The Slp4-a Linker Domain Controls Exocytosis through Interaction with Munc18-1{middle dot}Syntaxin-1a Complex [8].
 

Biological context of Linker

  • Here we have examined how amino acid sequences encompassing the dual phosphorylation motif located in the loop 12 linker (L12) between kinase subdomains VII and VIII and the length and amino acid sequence of L12 influence autophosphorylation, substrate specificity, and upstream kinase selectivity for the MAPK p38 [9].
  • Overexpression of the Linker histone-binding protein tNASP affects progression through the cell cycle [10].
  • The "Linker" Region (Amino Acids 38-47) of the Disintegrin Elegantin Is a Novel Inhibitory Domain of Integrin {alpha}5beta1-Dependent Cell Adhesion on Fibronectin: EVIDENCE FOR THE NEGATIVE REGULATION OF FIBRONECTIN SYNERGY SITE BIOLOGICAL ACTIVITY [11].
  • In this study, green fluorescent protein was fused to full-length CheB or its various parts: the N-terminal regulatory domain (N), the C-terminal catalytic domain (C) and the linker (L) [12].
  • The plasmids were made in two configurations, expressing either the VH (pc1A7VHLnVL) or the VL (pc1A7VLLnVH) chain of 1A7 at the amino terminus, linked together by a 15-amino acid linker (Ln) [13].
 

Anatomical context of Linker

  • Red blood cells were labeled using PKH26-GL Red Fluorescent Cell Linker and served as a marker for blood flow and volume [14].
 

Associations of Linker with other chemical compounds

  • Proteolytic Cleavage of the Linker Region of the Human P-glycoprotein Modulates Its ATPase Function [15].
  • The enzyme heparinase (Linker & Hovingh 1972) has been used successfully to eliminate heparin inhibition from DNA samples post-extraction, because the normal range of DNA extraction techniques fail to do so (Beutler et al. 1990; Oberhauser et al. 1994; Taylor et al. 1994) [16].
  • The adapter molecule LAT (Linker for the Activation of T cells) is a membrane protein that becomes phosphorylated on conserved tyrosine residues upon TCR/CD3 complex engagement in T lymphocytes [17].
 

Gene context of Linker

  • Studies of MRP1 topology suggested the presence of a hydrophobic N-domain with five potential membrane-spanning domains linked to an MDR1-like core (MSD1-NBD1-L1-MSD2-NBD2) by an intracellular linker domain (L0) [18].
  • A recombinant PTK6 Kinase domain connected to the Linker region had catalytic activity in terms of autophosphorylation, phosphorylation of a PTK6 substrate, BKS, and phosphorylation of an oligopeptide substrate, whereas the Kinase domain itself, or one connected to a Linker region containing a W184A substitution, did not [19].
  • A Smad4 construct, S4AF, consisting of the middle linker (L) domain and the C-terminal (C) domain, is shown to be a monomer, while a Smad3 construct, S3LC, consisting of the LC domains, is shown to form a trimer with an affinity K(3) = (1.2-3.1) x 10(9) M(-2) [20].
  • A construct with a 22-amino-acid flexible linker (L22) between the HBEGF and SAP moieties exhibited an affinity for the EGFR that was comparable to that of HBEGF [21].
  • Co-expression of the core with the N-terminal region including L0 fully restored MRP1 function [22].
 

Analytical, diagnostic and therapeutic context of Linker

References

  1. Epidermolysis bullosa simplex (Weber-Cockayne) associated with a novel missense mutation of Asp328 to Val in Linker 12 domain of keratin 5. Matsuki, M., Hashimoto, K., Yoshikawa, K., Yasuno, H., Yamanishi, K. Hum. Mol. Genet. (1995) [Pubmed]
  2. Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias. Frankel, A.E., McCubrey, J.A., Miller, M.S., Delatte, S., Ramage, J., Kiser, M., Kucera, G.L., Alexander, R.L., Beran, M., Tagge, E.P., Kreitman, R.J., Hogge, D.E. Leukemia (2000) [Pubmed]
  3. Targeted prodrug treatment of HER-2-positive breast tumor cells using trastuzumab and paclitaxel linked by A-Z-CINN Linker. Gilbert, C.W., McGowan, E.B., Seery, G.B., Black, K.S., Pegram, M.D. J. Exp. Ther. Oncol. (2003) [Pubmed]
  4. Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. Matsumoto, R., Wang, D., Blonska, M., Li, H., Kobayashi, M., Pappu, B., Chen, Y., Wang, D., Lin, X. Immunity (2005) [Pubmed]
  5. Regulation of transcription of immunoglobulin germ-line gamma 1 RNA: analysis of the promoter/enhancer. Xu, M.Z., Stavnezer, J. EMBO J. (1992) [Pubmed]
  6. LAT: a T lymphocyte adapter protein that couples the antigen receptor to downstream signaling pathways. Sommers, C.L., Samelson, L.E., Love, P.E. Bioessays (2004) [Pubmed]
  7. The Role of X/Y Linker Region and N-terminal EF-hand Domain in Nuclear Translocation and Ca2+ Oscillation-inducing Activities of Phospholipase C{zeta}, a Mammalian Egg-activating Factor. Kuroda, K., Ito, M., Shikano, T., Awaji, T., Yoda, A., Takeuchi, H., Kinoshita, K., Miyazaki, S. J. Biol. Chem. (2006) [Pubmed]
  8. The Slp4-a Linker Domain Controls Exocytosis through Interaction with Munc18-1{middle dot}Syntaxin-1a Complex. Tsuboi, T., Fukuda, M. Mol. Biol. Cell (2006) [Pubmed]
  9. Structure-function studies of p38 mitogen-activated protein kinase. Loop 12 influences substrate specificity and autophosphorylation, but not upstream kinase selection. Jiang, Y., Li, Z., Schwarz, E.M., Lin, A., Guan, K., Ulevitch, R.J., Han, J. J. Biol. Chem. (1997) [Pubmed]
  10. Overexpression of the Linker histone-binding protein tNASP affects progression through the cell cycle. Alekseev, O.M., Bencic, D.C., Richardson, R.T., Widgren, E.E., O'Rand, M.G. J. Biol. Chem. (2003) [Pubmed]
  11. The "Linker" Region (Amino Acids 38-47) of the Disintegrin Elegantin Is a Novel Inhibitory Domain of Integrin {alpha}5beta1-Dependent Cell Adhesion on Fibronectin: EVIDENCE FOR THE NEGATIVE REGULATION OF FIBRONECTIN SYNERGY SITE BIOLOGICAL ACTIVITY. Sumathipala, R., Xu, C., Seago, J., Mould, A.P., Humphries, M.J., Craig, S.E., Patel, Y., Wijelath, E.S., Sobel, M., Rahman, S. J. Biol. Chem. (2006) [Pubmed]
  12. Targeting of the chemotaxis methylesterase/deamidase CheB to the polar receptor-kinase cluster in an Escherichia coli cell. Banno, S., Shiomi, D., Homma, M., Kawagishi, I. Mol. Microbiol. (2004) [Pubmed]
  13. Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2. Zeytin, H.E., Tripathi, P.K., Bhattacharya-Chatterjee, M., Foon, K.A., Chatterjee, S.K. Cancer Gene Ther. (2000) [Pubmed]
  14. Methods to track leukocyte and erythrocyte transit through the bronchial vasculature in sheep. Gallagher, S.J., Shank, J.A., Bochner, B.S., Wagner, E.M. J. Immunol. Methods (2002) [Pubmed]
  15. Proteolytic Cleavage of the Linker Region of the Human P-glycoprotein Modulates Its ATPase Function. Nuti, S.L., Rao, U.S. J. Biol. Chem. (2002) [Pubmed]
  16. Titration of heparinase for removal of the PCR-inhibitory effect of heparin in DNA samples. Taylor, A.C. Mol. Ecol. (1997) [Pubmed]
  17. Activation of T lymphocytes and the role of the adapter LAT. Aguado, E., Mart??nez-Florensa, M., Aparicio, P. Transpl. Immunol. (2006) [Pubmed]
  18. Major photoaffinity drug binding sites in multidrug resistance protein 1 (MRP1) are within transmembrane domains 10-11 and 16-17. Daoud, R., Julien, M., Gros, P., Georges, E. J. Biol. Chem. (2001) [Pubmed]
  19. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6. Kim, H.I.e., Lee, S.T. J. Biol. Chem. (2005) [Pubmed]
  20. Sedimentation studies reveal a direct role of phosphorylation in Smad3:Smad4 homo- and hetero-trimerization. Correia, J.J., Chacko, B.M., Lam, S.S., Lin, K. Biochemistry (2001) [Pubmed]
  21. Targeting tumor cells via EGF receptors: selective toxicity of an HBEGF-toxin fusion protein. Chandler, L.A., Sosnowski, B.A., McDonald, J.R., Price, J.E., Aukerman, S.L., Baird, A., Pierce, G.F., Houston, L.L. Int. J. Cancer (1998) [Pubmed]
  22. Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. Bakos, E., Evers, R., Szakács, G., Tusnády, G.E., Welker, E., Szabó, K., de Haas, M., van Deemter, L., Borst, P., Váradi, A., Sarkadi, B. J. Biol. Chem. (1998) [Pubmed]
  23. Whole genome amplification for CGH analysis: Linker-adapter PCR as the method of choice for difficult and limited samples. Pirker, C., Raidl, M., Steiner, E., Elbling, L., Holzmann, K., Spiegl-Kreinecker, S., Aubele, M., Grasl-Kraupp, B., Marosi, C., Micksche, M., Berger, W. Cytometry. Part A : the journal of the International Society for Analytical Cytology. (2004) [Pubmed]
  24. Mass Spectrometric Mapping of Linker Histone H1 Variants Reveals Multiple Acetylations, Methylations, and Phosphorylation as Well as Differences between Cell Culture and Tissue. Wisniewski, J.R., Zougman, A., Kr??ger, S., Mann, M. Mol. Cell Proteomics (2007) [Pubmed]
 
WikiGenes - Universities